Skip to main content

Table 4 Effectiveness, costs and setting of interventional treatments

From: Impact of radiofrequency ablation for patients with varicose veins on the budget of the German statutory health insurance system

Parameter

Value

Source

Interventional treatment effectiveness

  

Monthly probability of recurrence after 1st and 2nd treatment

  

Surgery

0.00833

NICE [44]

ClosureFast

0.00833

Assumption

UGFS

0.00914

NICE [44]

Probability of top-up treatment

  

Surgery

0.05

NICE [44]

ClosureFast

0.05

NICE[44]

UGFS

0.20

NICE [44]

Probability of receiving 2nd intervention after recurrence

0.75

NICE [44]

Treatment setting and costs

  

Outpatient treatment proportion

  

Surgery

0.60

Assumption

ClosureFast

0.90

Assumption

UGFS

1.00

Assumption

Inpatient treatment costs

  

Surgery

2,218.02 €

DRG F39b

ClosureFast

2,218.02 €

DRG F39b

Outpatient treatment costs

  

Surgery

639.45 €

OPS-Code 5–385.70*

ClosureFast

1,100.00 €

Assumption**

UGFS

47.23 €***

EBM-Codes 03111, 30501, 30500

Monthly costs of conservative compression therapy

11.45 €

Kemper et al. [72]

  1. * incl. operation and post-operative treatment.
  2. ** Average reimbursement in sub contracts between manufacturer and statutory health insurance funds.
  3. *** EBM-Code 03111: 30.84 €, EBM-Code 30500: 16.30 €, EBM-Code 30501: 9.29 €.